Free Trial
ETR:SRT

Sartorius Aktiengesellschaft (SRT) Stock Price, News & Analysis

Sartorius Aktiengesellschaft logo
€175.40 +2.54 (+1.47%)
As of 03/28/2025

About Sartorius Aktiengesellschaft Stock (ETR:SRT)

Key Stats

Today's Range
€172.00
€179.40
50-Day Range
€171.40
€226.00
52-Week Range
€164.80
€290.00
Volume
1,697 shs
Average Volume
N/A
Market Capitalization
$13.63 billion
P/E Ratio
88.23
Dividend Yield
0.42%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Remove Ads
Receive SRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SRT Stock News Headlines

Sartorius Aktiengesellschaft (SRT.F)
Sartorius AG
Do this Before Elon's Reveal on April 23rd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
Sartorius Aktiengesellschaft (4SRT3.TI)
SRT.DE - Sartorius Aktiengesellschaft
EQS-News: SARTORIUS AG: Sartorius announces CFO transition
Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht
Sartorius AG (SRT.HM)
See More Headlines

SRT Stock Analysis - Frequently Asked Questions

Sartorius Aktiengesellschaft's stock was trading at €172.40 on January 1st, 2025. Since then, SRT shares have increased by 1.7% and is now trading at €175.40.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Aktiengesellschaft investors own include American Eagle Outfitters (AEO), Bayer Aktiengesellschaft (BAYN), Align Technology (ALGN), Allianz (ALV), Gilead Sciences (GILD), Micron Technology (MU) and Maxim Integrated Products (MXIM).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Business Services
Current Symbol
ETR:SRT
CIK
N/A
Fax
N/A
Employees
45,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
88.23
Forward P/E Ratio
33.19
P/E Growth
2.28
Net Income
$155.09 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.74 billion
Cash Flow
€1.93 per share
Price / Cash Flow
91.09
Book Value
€54.71 per share
Price / Book
3.21

Miscellaneous

Free Float
N/A
Market Cap
$13.63 billion
Optionable
Not Optionable
Beta
0.93
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (ETR:SRT) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners